1 Min Read
May 11 (Reuters) - Adamas Pharmaceuticals Inc
* Entered into sales agreement with Cowen and co, relating to potential common stock offering of up to $50 million of its shares Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.